The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
Breast cancers arising in carriers of mutations in the breast cancer susceptibility genes, BRCA1 and BRCA2, differ histologically from each other and from breast cancers unselected for a family history. However, a substantial proportion of families with multiple cases of breast cancer is not attributable to these two genes (non-BRCA1/2 families). We have now characterized the pathology of 82 breast cancers from non-BRCA1/2 families. Breast cancers in non-BRCA1/2 families were of lower grade (P = 0.0018), showed fewer mitoses (P < 0.0001), less nuclear pleomorphism (P = 0.0014), less lymphocytic infiltrate (P < 0.0001), a lesser extent of the tumor with a continuous pushing margin (P = 0.004), a lesser extent of the tumor composed of solid sheets of cells (P = 0.0047), less necrosis (P = 0.002), and wereparison with BRCA2 tumors, non-BRCA1/2 tumors were lower grade (P = 0.017) and exhibited less pleomorphism (P = 0.01) and more tubule formation (P = 0.05). In comparison with control breast cancers unselected for a family history of the disease, non-BRCA1/2 tumors were of significantly lower grade (P = 0.001), showed less pleomorphism (P = 0.0002), and had a lower mitotic count (P = 0.003). The results indicate that non-BRCA1/2 breast cancers differ histologically from both BRCA1 and BRCA2 breast cancers and are overall of lower grade. They also suggest that non-BRCA1/2 breast cancers differ from nonfamilial breast cancers, but these differences may be attributable to various types of bias.
Lakhani
S R
SR
Department of Histopathology, University College London Medical School, United Kingdom.
Gusterson
B A
BA
Jacquemier
J
J
Sloane
J P
JP
Anderson
T J
TJ
van de Vijver
M J
MJ
Venter
D
D
Freeman
A
A
Antoniou
A
A
McGuffog
L
L
Smyth
E
E
Steel
C M
CM
Haites
N
N
Scott
R J
RJ
Goldgar
D
D
Neuhausen
S
S
Daly
P A
PA
Ormiston
W
W
McManus
R
R
Scherneck
S
S
Ponder
B A
BA
Futreal
P A
PA
Peto
J
J
Stoppa-Lyonnet
D
D
Bignon
Y J
YJ
Stratton
M R
MR
D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology*; D018270:Carcinoma, Ductal, Breast / Q000235:genetics / Q000473:pathology; D018275:Carcinoma, Lobular / Q000235:genetics / Q000473:pathology; D018276:Carcinoma, Medullary / Q000235:genetics / Q000473:pathology; D005192:Family Health; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating; D008940:Mitotic Index; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics
D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors